Stephen Kingston
Medical · Farmingville, NYNPI 1316064124
Payments from drug & device makers
Across 321 payments — averaging $23.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$1K
- AbbVie$1K
- Boehringer Ingelheim$584
- Novo Nordisk$518
- Johnson & Johnson$404
- plus $2K from 27 others
What the payments were for
- Food & beverage$7,601100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 62 | $1,551 |
| Lilly USA, LLC | 45 | $1,223 |
| AbbVie | 53 | $1,048 |
| Boehringer Ingelheim | 23 | $584 |
| Novo Nordisk | 31 | $518 |
| Johnson & Johnson | 10 | $404 |
| GSK | 12 | $331 |
| Axsome Therapeutics, Inc. | 5 | $309 |
| Pfizer | 12 | $253 |
| Exact Sciences | 9 | $202 |
| Daiichi Sankyo Inc. | 11 | $194 |
| Amarin Pharma, Inc. | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Amgen | 3 | $87 |
| Idorsia Pharmaceuticals US Inc | 4 | $79 |
| Boston Scientific | 2 | $75 |
| Corcept Therapeutics | 3 | $70 |
| Esperion Therapeutics, Inc. | 3 | $62 |
| Abbott | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Merck | 3 | $44 |
| Intra-sana Laboratories | 2 | $43 |
| Lundbeck LLC | 2 | $36 |
| Medicomp Inc | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Shield Therapeutics Inc | 1 | $23 |
| Smith+Nephew | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Avvisto Therapeutics, LLC | 1 | $20 |
| Averitas Pharma Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,613 in reported general payments places this provider in the 90th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 45 | $69,161 |
| MounjaroTirzepatide | 52 | $60,311 |
| TrulicityDulaglutide | 38 | $49,286 |
| FarxigaDapagliflozin Propanediol | 23 | $34,291 |
| EliquisApixaban | 15 | $24,518 |
| OzempicSemaglutide | 20 | $22,240 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,362 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $17,528 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $11,276 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $10,885 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $7,392 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,074 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,816 |
| Levothyroxine Sodium | 218 | $3,460 |
| Atorvastatin Calcium | 292 | $2,176 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $1,223 | $109,59690 claims |
| Boehringer IngelheimJardiance | $584 | $69,16145 claims |
| AstraZenecaFarxiga | $1,551 | $34,29123 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $331 | $32,25154 claims |
| MerckJanumet Xr, Janumet | $44 | $28,41423 claims |
| PfizerEliquis | $253 | $24,51815 claims |
| Novo NordiskOzempic | $518 | $22,24020 claims |
| AbbVieSynthroid | $1,048 | $1,33225 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,395 medical providers in New York.
Other medical in Farmingville
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.